SBC Medical Group Holdings Incorporated Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SBC Medical Group Holdings Incorporated (SBC) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $67.11 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $47.44K, a 2481.18% increase year-over-year.
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $19.66K, a 80.83% decline year-over-year.
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $1.22M.
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $1.12K.
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.32M.
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $2.31M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $67.11K 10-Q · filed 2026-08-13 | $1.28M derived: sum of 3 quarters · filed 2026-08-13 | $1.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $19.66K 10-Q · filed 2026-05-14 | $1.24M derived: sum of 2 quarters · filed 2026-05-14 | $1.24M derived: sum of 3 quarters · filed 2026-05-14 | $1.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.22M derived: sum of 2 quarters · filed 2026-03-27 | $1.22M derived: sum of 3 quarters · filed 2026-08-13 | $1.32M 10-K · filed 2026-03-27 |
| 2025-09-30 | $1.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.96K derived: sum of 2 quarters · filed 2026-08-13 | $105.56K 10-Q · filed 2025-11-14 | $105.56K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $104.44K 10-Q · filed 2026-08-13 | $104.44K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-03-31 | $102.60K 10-Q · filed 2026-05-14 | $102.60K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.31M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $1.03M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |